Skip to content

Total Assets at other companies

Arrowhead Research logo
Arrowhead ResearchARWR
$2.27B+44.2%
ALN
Alnylam PharmaceuticalsALNY
$5.13B+21.7%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$99.89M-27.9%
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
$277.16M+137%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$1.03B-21.6%
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
$713.22M-25.7%

Other financials

Income statement

See full
Revenue$8.2M-12.8%
Operating income-$11.4M-14.4%
Net income-$9.1M-3.0%
EPS (diluted)-$0.54+53.8%

Balance sheet

See full
Cash & equivalents$31.1M+32.9%
Total debt$2.5M-17.5%
Total equity$198.6M+632%

Cash flow

See full
Operating cash flow-$22.1M+5.7%
CapEx$19.0K
Free cash flow-$22.1M+5.6%

Valuation

See full
Market cap$480.77M+262%
Enterprise value$452.14M+302%
P/S6.8×+2.6×

Profitability

See full
Operating margin-116.8%-26.1pp
Net margin-103.6%-22.7pp
FCF margin-150%-231pp

Returns & leverage

See full
Return on equity-36.9%-15.1pp
Debt / equity-0.1×
Current ratio6.6×+4.6×

Where this comes from

Reported directly by Assembly Biosciences in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Assembly Biosciences's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Assembly Biosciences's total assets?
Assembly Biosciences (ASMB) reported total assets of $235.51M in Q1 2026.
How has Assembly Biosciences's total assets changed year-over-year?
Assembly Biosciences's total assets increased by 137.8% year-over-year, from $99.02M to $235.51M.
What is the long-term trend for Assembly Biosciences's total assets?
Over 5 years (2020 to 2025), Assembly Biosciences's total assets has grown at a -1.9% compound annual growth rate (CAGR), from $283.25M to $257.59M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.